Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.

Chen L, Davey Smith G, Evans DM, Cox A, Lawlor DA, Donovan J, Yuan W, Day IN, Martin RM, Lane A, Rodriguez S, Davis M, Zuccolo L, Collin SM, Hamdy F, Neal D, Lewis SJ.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2874-81. doi: 10.1158/1055-9965.EPI-09-0544. Review.

2.

Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.

Coşkun S, Şimşek Ş, Camkurt MA, Çim A, Çelik SB.

Gene. 2016 Aug 22;588(2):109-14. doi: 10.1016/j.gene.2016.05.004.

PMID:
27155524
3.

Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.

Zhang Q, Shan Y.

J BUON. 2013 Oct-Dec;18(4):961-9. Review.

PMID:
24344024
4.

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90.

5.

Vitamin D receptor genotypes/haplotypes and prostate cancer risk.

Cicek MS, Liu X, Schumacher FR, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2549-52.

6.

Associations among four polymorphisms (BsmI, FokI, TaqI and ApaI) of vitamin D receptor gene and end-stage renal disease: a meta-analysis.

Yang L, Wu L, Fan Y, Ma J.

Arch Med Res. 2015 Jan;46(1):1-7. doi: 10.1016/j.arcmed.2014.11.017. Review. Erratum in: Arch Med Res. 2015 Feb;46(2):172.

PMID:
25434518
7.

Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.

Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T.

Cancer Res. 2000 Jan 15;60(2):305-8.

8.

ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks.

Čierny D, Michalik J, Škereňová M, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Lehotský J.

Neurol Res. 2016 Aug;38(8):678-84. doi: 10.1080/01616412.2016.1200287.

PMID:
27338176
9.

Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China.

Bai Y, Yu Y, Yu B, Ge J, Ji J, Lu H, Wei J, Weng Z, Tao Z, Lu J.

BMC Med Genet. 2009 Dec 4;10:125. doi: 10.1186/1471-2350-10-125.

10.

Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.

Huang SP, Chou YH, Wayne Chang WS, Wu MT, Chen YY, Yu CC, Wu TT, Lee YH, Huang JK, Wu WJ, Huang CH.

Cancer Lett. 2004 Apr 15;207(1):69-77.

PMID:
15050735
11.

Vitamin D receptor polymorphisms and prostate cancer.

Blazer DG 3rd, Umbach DM, Bostick RM, Taylor JA.

Mol Carcinog. 2000 Jan;27(1):18-23.

PMID:
10642433
12.

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA.

J Natl Cancer Inst. 1997 Jan 15;89(2):166-70.

PMID:
8998186
13.

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.

Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.

PLoS Med. 2007 Mar;4(3):e103.

14.

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S.

Cancer Detect Prev. 2009;32(5-6):386-94.

PMID:
19588543
15.

A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk.

Berndt SI, Dodson JL, Huang WY, Nicodemus KK.

J Urol. 2006 May;175(5):1613-23.

PMID:
16600714
16.

Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.

Guo Z, Wen J, Kan Q, Huang S, Liu X, Sun N, Li Z.

Tumour Biol. 2013 Oct;34(5):3189-200. doi: 10.1007/s13277-013-0889-6.

PMID:
23807674
17.

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.

Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9.

18.

Association of vitamin D receptor BsmI (rs1544410), Fok1 (rs2228570), TaqI (rs731236) and ApaI (rs7975232) gene polymorphism with the nephrolithiasis susceptibility.

Zhou TB, Jiang ZP, Li AH, Ju L.

J Recept Signal Transduct Res. 2015 Apr;35(2):107-14. doi: 10.3109/10799893.2014.936459.

PMID:
25051494
19.

Polymorphisms in the vitamin D receptor gene and risk of lung cancer.

Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A.

Med Sci Monit. 2009 Aug;15(8):BR232-42.

PMID:
19644412
20.

Vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D₃ in patients with Graves disease in an Egyptian population: a pilot study.

Abd El Gawad SS, Abdul Samee ER, Metwali AA, Abd El Gawad MS.

Endocr Pract. 2012 Mar-Apr;18(2):132-9. doi: 10.4158/EP11131.OR.

PMID:
21803714

Supplemental Content

Support Center